Anticipating mental health needs after chemotherapy in early-stage breast cancer using patient-reported symptom screening.
Zev M NakamuraEmily M DamoneHannah P HerrickKirsten A NyropAllison M DealA Tucker BrenizerHyman B MussPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
Diagnosis of and treatment for depression and anxiety are common among women with breast cancer after completing chemotherapy. Prescriptions for psychotropic medications during the initial years after systemic chemotherapy can be anticipated by depression and anxiety screening at end of chemotherapy.